We are live on
!
Find out more
BCM
Bienville Capital Management Portfolio holdings
AUM
$550M
1-Year Est. Return
3.49%
This Fund
S&P 500
This Quarter
Est. Return
-6.46%
1 Year Est. Return
-3.49%
3 Year Est. Return
+22.26%
5 Year Est. Return
+37.68%
10 Year Est. Return
+234.7%
AUM
$121M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow
% of AUM
106.37%
Top 10 Holdings %
Top 10 Hldgs %
62.53%
Holding
103
New
103
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
|
+$25.2M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$14.4M |
| 3 |
Pampa Energía
PAM
|
+$8.91M |
| 4 |
Telecom Argentina
TEO
|
+$8.89M |
| 5 |
PZE
Petrobras Argentina S A
PZE
|
+$8.32M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 25.64% |
| 2 | Healthcare | 13.34% |
| 3 | Industrials | 8.2% |
| 4 | Communication Services | 7.26% |
| 5 | Financials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVS Health
CVS
$120B
| $337K | 0.28% |
+3,500
| New | +$308K |
|
52
DexCom
DXCM
$33.4B
| $330K | 0.27% |
+24,000
| New | +$294K |
|
53
Regeneron Pharmaceuticals
REGN
$83.1B
| $328K | 0.27% |
+800
| New | +$315K |
|
|
OCR
54
DELISTED
OMNICARE INC
OCR
| $328K | 0.27% |
+4,500
| New | +$305K |
|
|
SLXP
55
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $322K | 0.27% |
+2,800
| New | +$339K |
|
|
MDVN
56
DELISTED
MEDIVATION, INC.
MDVN
| $319K | 0.26% |
+6,400
| New | +$333K |
|
57
Southern Company
SO
$106B
| $317K | 0.26% |
+6,464
| New | +$305K |
|
58
Illumina
ILMN
$29B
| $314K | 0.26% |
+1,748
| New | +$308K |
|
59
Pacira BioSciences
PCRX
$976M
| $310K | 0.26% |
+3,500
| New | +$331K |
|
60
GSK
GSK
$102B
| $306K | 0.25% |
+5,734
| New | +$321K |
|
|
WBA
61
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $305K | 0.25% |
+4,000
| New | +$267K |
|
62
Incyte
INCY
$24.5B
| $292K | 0.24% |
+4,000
| New | +$261K |
|
63
Procter & Gamble
PG
$337B
| $291K | 0.24% |
+3,200
| New | +$282K |
|
64
CALL
Global X MSCI Argentina ETF
ARGT
$820M
| $281K | 0.23% |
+15,000
| New | +$299K |
|
65
Edwards Lifesciences
EW
$53.9B
| $280K | 0.23% |
+13,200
| New | +$265K |
|
|
DPLO
66
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $274K | 0.23% |
+10,000
| New | +$243K |
|
67
Perrigo
PRGO
$1.75B
| $267K | 0.22% |
+1,600
| New | +$250K |
|
68
PUT
Alerian Energy Infrastructure ETF
ENFR
$526M
| $263K | 0.22% |
+15,000
| New | +$429K |
|
69
Centene
CNC
$32.4B
| $260K | 0.21% |
+10,000
| New | +$233K |
|
70
Seagate
STX
$186B
| $259K | 0.21% |
+3,900
| New | +$242K |
|
71
United Therapeutics
UTHR
$22.4B
| $259K | 0.21% |
+2,000
| New | +$258K |
|
|
TTPH
72
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $258K | 0.21% |
+325
| New | +$175K |
|
73
Cigna
CI
$72.1B
| $257K | 0.21% |
+2,500
| New | +$246K |
|
74
Waste Management
WM
$91.3B
| $257K | 0.21% |
+5,000
| New | +$243K |
|
|
NVO
75
Novo Nordisk
NVO
$207B
| $254K | 0.21% |
+12,000
| New | +$268K |
|
Similar funds
IQI
LWP
BT
WCP
TC
SVCM
CA
HIS
Bienville Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Bienville Capital Management, which disclosed 103 positions worth $121M. Its ten largest holdings account for 63% of the portfolio.
Its largest position is YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock): 815,903 shares worth $21.6M.
By sector, the portfolio is most concentrated in Energy at 26% of assets, followed by Healthcare and Industrials.
- Bienville Capital Management's largest Q4 2014 buy was YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock): 815,903 shares worth $21.6M.
- Bienville Capital Management's ten largest holdings make up 63% of its $121M portfolio in Q4 2014.
- Bienville Capital Management disclosed 103 positions in Q4 2014, its first 13F filing on record.
Based on Bienville Capital Management's 13F filing for Q4 2014, filed 18 Feb 2015.